177 Results

People

  1. Kris
    Kris
  2. Miller
    Miller
  3. Riely
    Riely
  4. Krug
    Krug
  5. Rusch
    Rusch
  6. Heelan
    Heelan
  7. Tyson
    Tyson
  8. Azzoli
    Azzoli
  9. Gralla
    Gralla
  10. Rizvi
    Rizvi

Groups

  1. Department of Medicine (177)
  2. Solid Tumor Oncology Division (177)
  3. Thoracic Oncology (177)
  4. Nursing (45)
  5. GSK Faculty (36)
  6. Epidemiology and Biostatistics (35)
  7. Surgery (35)
  8. Biostatistics Service (33)
  9. Survivorship Research (31)
  10. Radiology, Department of (30)
  1. "adult"
  2. "Mark Kris"
  3. "Journal article"
Formats
  1. Journal Article (177)
Groups
  1. Department of Medicine (177)
  2. Solid Tumor Oncology Division (177)
  3. Thoracic Oncology (177)
  4. Nursing (45)
  5. GSK Faculty (36)
  6. Epidemiology and Biostatistics (35)

More Groups

People
  1. Mark Kris (177)
  2. Vincent Miller (56)
  3. Gregory Riely (38)
  4. Lee Krug (35)
  5. Valerie Rusch (30)
  6. Robert Heelan (29)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2020 (1)
  4. 2019 (3)
  5. 2018 (3)
  6. 2015 (8)

More Years

Publications
  1. Cancer (27)
  2. Clinical Cancer Research (26)
  3. Journal of Clinical Oncology (16)
  4. Journal of Thoracic Oncology (15)
  5. American Journal of Clinical Oncology (9)
  6. Cancer Chemotherapy and Pharmacology (9)

More Publications

Publishers
  1. American Association for Cancer Research (31)
  2. Wiley Blackwell (29)
  3. Elsevier Inc. (22)
  4. American Society of Clinical Oncology (18)
  5. Springer (16)
  6. Oxford University Press (12)

More Publishers

Results (177)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Luo, J.; Ai, N.; Kim, R.; Ahn, L.; Biswas, A.; Coker, C.; Ma, W.; Wong, P.; Buonocore, D. J.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Deciphering radiological stable disease to immune checkpoint inhibitors
    Journal Article

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Callahan, M. K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Novel germline mutations in DNA damage repair in patients with malignant pleural mesotheliomas
    Journal Article

    Guo, R.; DuBoff, M.; Jayakumaran, G.; Kris, M. G.; Ladanyi, M.; Robson, M. E.; Mandelker, D.; Zauderer, M. G.
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Creating a synthetic clinical trial: Comparative effectiveness analyses using an electronic medical record
    Journal Article

    Zauderer, M. G.; Grigorenko, A.; May, P.; Kastango, N.; Wagner, I.; Caroline, A.; Kris, M. G.
    JCO Clinical Cancer Informatics (2019)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Therapeutic potential of afatinib for cancers with ERBB2 (HER2) transmembrane domain mutations G660D and V659E
    Journal Article

    Yamamoto, H.; Toyooka, S.; Ninomiya, T.; Matsumoto, S.; Kanai, M.; Tomida, S.; Kiura, K.; Muto, M.; Suzawa, K.; Desmeules, P.; more...
    The Oncologist (2018)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save